Research and Markets: 2009 Chemicals, Pharmaceuticals, Medical Products & Biotechnology - UK Key Corporate Changes

* Reuters is not responsible for the content in this press release.

Thu Oct 8, 2009 7:33am EDT

DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/288211/2009_chemicals_ph) has
announced the addition of the "2009 Chemicals, Pharmaceuticals, Medical Products
& Biotechnology - UK Key Corporate Changes" report to their offering. 

The Mandis 2009 Key Corporate Changes report for the UK Chemicals,
Pharmaceuticals, Medical Products & Biotechnology Sector will put you ahead of
your competition in terms of market knowledge. This is an in depth report
detailing 1332 key changes and developments, covering 718 different companies.
These are the Key Corporate Changes that have occurred within or to the relevant
market participants and that can be considered to have shaped and influenced the
overall UK market during the year. 

The report includes over 363 pages of Key Corporate Changes including:

* 433 changes driving Job Creation and highlighting growth companies, 
* 163 changes giving rise to Redundancies, thus identifying companies that are
shrinking and may be potential take-over targets. 
* 250 product and service developments, which identifies those companies
responding to significant changes within their marketplace by varying their
product mix. 
* 142 significant Administrations or Liquidations, these may give rise to
opportunities for strong market players to cost effectively acquire new assets,
staff and clients. 
* 204 Major financial changes, which provides valuable market knowledge and
insights into the impact on performance of the key players due to of current
market forces.

This report is unique within the UK market, as it is the only sector report that
is based upon the Key Corporate Changes that have driven change in the market
and is completely up to date, as of the report date. The report condenses the
details of those change events into brief summaries. These would therefore
provide the perfect input to developing your own value added consultancy
reports, allowing you to add depth and facts by including specific details of
developments within individual companies. The report comprises two principal
sections. 

The first section consists of a one-line synopsis of every corporate change
covered in the report. In this section, organisations with two or more change
summaries have been grouped by organisation and indexed alphabetically by
organisation name. Within organisation name, the summaries are listed in
descending date order with the latest dated summary shown first. For
organisations with only a single change summary in the report period, the
information is grouped under Other Organisations and is shown in descending date
order. The only exceptions to this being those summaries that are considered
exceptionally important; these are then also shown under the separate
organisation name in the index of organisations. 

The second section comprises the detailed text of every event summary covered in
the report, each of which is headed by the date and the organisation name. The
information is grouped by the type of dynamic change covered by the event
summary and is shown in descending date order within that section. 

Key Topics Covered:

* 1. Introduction 
* 2. Event Summary Synopsis 
* 3. Event Summary Detail 
* 3.1 Product and Service developments 
* 3.2 Financial changes - growth, decline 
* 3.3 Acquisitions & fund raising 
* 3.3.1 Administrators/Liquidators 
* 3.3.2 Mergers & Acquisition 
* 3.4 Relocations new outlets, plant developments 
* 3.5 Organisational restructuring 
* 3.5.1 Redundancy Announcements 
* 3.5.2 New Staff Announcements 
* 3.5.3 Redeployment Announcements 
* Companies Mentioned

For more information visit
http://www.researchandmarkets.com/research/288211/2009_chemicals_ph

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716 

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.